Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Glaukos Corp 1 GLAUKOS WAY ALISO VIEJO CA 92656 USA

www.glaukos.com Employees: 995 P: 949-367-9600 F: 949-367-9984

Sector:

Medical

Description:

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.

Key Statistics

Overview:

Market Capitalization, $K 6,907,708
Enterprise Value, $K 6,738,078
Shares Outstanding, K 57,435
Float, K 54,104
% Float 94.20%
Short Interest, K 2,483
Short Float 4.32%
Days to Cover 2.46
Short Volume Ratio 0.72
% of Insider Shareholders 5.80%
% of Institutional Shareholders 99.04%

Financials:

Annual Sales, $ 383,480 K
Annual Net Income, $ -146,370 K
Last Quarter Sales, $ 133,540 K
Last Quarter Net Income, $ -16,230 K
EBIT, $ -88,410 K
EBITDA, $ -51,810 K

Growth:

1-Year Return -23.57%
3-Year Return 152.67%
5-Year Return 27.19%
5-Year Revenue Growth 61.82%
5-Year Earnings Growth -1,760.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 02/17/26
Next Earnings Date 04/29/26
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Qtr -75.00%
EPS Growth vs. Prev Year 30.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

GKOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -7.00%
Return-on-Assets % -5.38%
Profit Margin % -38.17%
Debt/Equity 0.00
Price/Sales 13.25
Price/Cash Flow 110.03
Price/Book 10.25
Book Value/Share 13.40
Interest Coverage -13.50
60-Month Beta 0.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar